Genetic Risk Score, Combined Lifestyle Factors and Risk of Colorectal Cancer

Young Ae Cho; Jeonghee Lee; Jae Hwan Oh; Hee Jin Chang; Dae Kyung Sohn; Aesun Shin; Jeongseon Kim

doi:10.4143/crt.2018.447

Articles

Page Path: HOME > Cancer Res Treat > Volume 51(3); 2019 > Article

Original Article Genetic Risk Score, Combined Lifestyle Factors and Risk of Colorectal Cancer: Young Ae Cho, PhD, MPH¹, Jeonghee Lee, MS¹, Jae Hwan Oh, MD, PhD², Hee Jin Chang, MD, PhD², Dae Kyung Sohn, MD, PhD², Aesun Shin, MD, PhD³, Jeongseon Kim, PhD^1,; Cancer Research and Treatment : Official Journal of Korean Cancer Association 2019;51(3):1033-1040.
DOI: https://doi.org/10.4143/crt.2018.447
Published online: October 18, 2018

¹Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

²Center for Colorectal Cancer, National Cancer Center Hospital, National Cancer Center, Goyang, Korea

³Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea

Correspondence: Jeongseon Kim, PhD Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea
Tel: 82-31-920-2570 Fax: 82-31-920-2579 E-mail: jskim@ncc.re.kr

• Received: August 8, 2018 • Accepted: October 17, 2018

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

19,632 Views
480 Download
66 Web of Science
62 Crossref
69 Scopus

prev next

Full Article

Download PDF

Abstract

Purpose
Both genetic and lifestyle factors contribute to the risk of colorectal cancer, but each individual factor has a limited effect. Therefore, we investigated the association between colorectal cancer and the combined effects of genetic factors or/and lifestyle risk factors.
Materials and Methods
In a case-control study of 632 colorectal cancer patients and 1,295 healthy controls, we quantified the genetic risk score for colorectal cancer using 13 polymorphisms. Furthermore, we determined a combined lifestyle risk score including obesity, physical activity, smoking, alcohol consumption, and dietary inflammatory index. The associations between colorectal cancer and risk score using these factors were examined using a logistic regression model.
Results
Higher genetic risk scores were associated with an increased risk of colorectal cancer (odds ratio [OR], 2.57; 95% confidence interval [CI], 1.89 to 3.49 for the highest tertile vs. lowest tertile). Among the modifiable factors, previous body mass index, physical inactivity, heavy alcohol consumption, and a high inflammatory diet were associated with an increased risk of colorectal cancer. A higher lifestyle risk score was associated with an increased risk of colorectal cancer (OR, 5.82; 95% CI, 4.02 to 8.44 for the highest tertile vs. lowest tertile). This association was similar in each genetic risk category.
Conclusion
Adherence to a healthy lifestyle is associated with a substantially reduced risk of colorectal cancer regardless of individuals’ genetic risk.
Key words: Colorectal cancer, Genes, Lifestyle, Risk score

Introduction

Colorectal cancer is the third most common cancer in men and the second most common cancer in women worldwide [1]. A family history of colorectal cancer is an independent risk factor, suggesting that inherited DNA sequence variants contribute to the causation of colorectal cancer [2]. Recently, several genome-wide association studies have identified polymorphisms associated with colorectal cancer risk [3-6]. However, the increase in the colorectal cancer rates in several Asian and Eastern European countries may be due to the shift from a traditional lifestyle toward a Westernized lifestyle following by the rapid economic development [7]. The unhealthy lifestyle likely contributes to the growing colorectal cancer rate in certain countries [8]. Thus, modifying these lifestyle factors has the preventive potential in colorectal cancer.

Although both genetic and lifestyle factors affect the risk of colorectal cancer, no single component can explain the large international variation in the incidence of colorectal cancer [9]. Several previous studies have used a genetic risk score to predict individuals’ predetermined risk [3,10]. Additionally, some previous studies have examined the association between combined lifestyle factors and the incidence of colorectal cancer [11-14]. However, these studies are not comparable due to the use of different lifestyle factors, different cut-off points and different scoring systems [11]. From a public health point of view, the incidence of colorectal cancer may be reduced by modifying lifestyle risk factors and screening individuals at a high risk. However, few studies have examined the association between combined genetic and lifestyle factors and the risk of developing colorectal cancer.

Thus, we constructed a genetic risk score using validated common colorectal cancer susceptibility loci identified from genome-wide association studies. In addition, we aimed to identify modifiable lifestyle factors and develop a combined risk score, and determine whether lifestyle factors are affected differently by un-modifiable risk factors, such as genetic factors.

Materials and Methods

1. Study populations

This study included cases of newly diagnosed colorectal cancer patients at the Center for Colorectal Cancer of the National Cancer Center, Korea, between August 2010 and August 2013. Of the 925 patients who agreed to participate in the study and completed the questionnaires, two patients were excluded due to implausible energy intakes. In total, 923 patients were included in the analysis. The control participants were recruited between October 2007 and December 2014 among individuals visiting the Center for Cancer Prevention and Detection at the same hospital for a health check-up program provided by the National Health Insurance Cooperation, which covers the entire Korean population. Of the 9,157 healthy subjects who agreed to participate in the study and completed the questionnaires, 120 subjects were excluded due to the implausible energy intake. Of the remaining 9,037 individuals, two controls per case were randomly selected and frequency-matched by gender and 5-year age group. Additionally, individuals with missing blood samples and genotyping data were excluded. Ultimately, 632 colorectal cancer patients and 1,295 healthy controls were included in the final analysis (S1 Fig.).

2. Assessment of modifiable lifestyle risk factors

Information regarding the participants’ demographic and lifestyle risk factors (e.g., smoking, alcohol consumption, and regular exercise) was collected by in-person interviews or structured questionnaires at initial recruitment, prior to cancer diagnosis. The dietary intake was assessed using a validated 106-item semi-quantitative food frequency questionnaire specifically developed for this population encompassing commonly consumed food items. The validity and reproducibility of the questionnaire have been previously reported [15]. Each participant provided their average frequency of eating and typical portion sizes in the year preceding the interview. These values were converted to obtain daily nutrient intake values using a scale with nine frequency categories and three portion size categories. We calculated the dietary inflammatory index (DII), and the calculation of the DII has been previously described [16,17]. In the present study, 35 food components were included to calculate DII: protein, fat, carbohydrate, fiber, monounsaturated fatty acid, saturated fatty acid, polyunsaturated fatty acid, n-3 fatty acid, n-6 fatty acid, cholesterol, thiamin, riboflavin, niacin, vitamin B₆, vitamin B₁₂, vitamin C, folic acid, vitamin A, vitamin D, vitamin E, β-carotene, iron, magnesium, selenium, zinc, garlic, ginger, onion, green tea, flavan-3-ol, fla-vone, flavonol, flavanone, anthocyanidin, and isoflavone.

3. Single-nucleotide polymorphism selection and genotyping

The single-nucleotide polymorphisms (SNPs) were selected as previously described [18]. Briefly, 30 SNPs were selected from the literature based on their association with colorectal cancer in previous genome-wide association studies [18]. Details regarding the selected SNPs are provided in S2 Table.

The genotyping was conducted as described below. Genomic DNA was extracted using the MagAttract DNA Blood M48 Kit (Qiagen, Hilden, Germany) and BioRobot M48 automatic extraction equipment (Qiagen) according to the manufacturer’s instructions. The genotyping was performed using a MassARRAY iPLEX Gold Assay (Agena Bioscience, San Diego, CA). To control the genotyping quality, duplicate samples of 3% of the subjects were included in our initial genotyping analysis; the rate of discordance was < 1%.

4. Construction of the unweighted and weighted genetic risk score

To construct the genetic risk score, the independent association between 30 SNPs and colorectal cancer was initially examined using a logistic regression under allele-based model. Among them, 13 SNPs were significantly associated with the risk of colorectal cancer in the present study. Therefore, these SNPs were used to calculate the genetic risk scores. We constructed both unweighted and weighted genetic risk scores [19]. The unweighted genetic risk scores of individual participants were created by adding the number of risk alleles (i.e., 0, 1, or 2) at each SNP. Additionally, we calculated the weighted genetic risk score by multiplying by the effect size (the SNP’s β coefficient from the current logistic regression model) in the current case-control study. The 13 products were then summed to create a weighted genetic risk score for each study participant.

5. Development of lifestyle risk score

We generated a modifiable lifestyle index based on a priori knowledge of risk factors for colorectal cancer and public health recommendations. The lifestyle factors were characterized as harmful based on their independent association with colorectal cancer. First, both current and previous (prior 2 years) body mass indexes (BMIs) were calculated because the current BMI could be affected by the disease status in the case-control studies [20]. The BMI was categorized according to the World Health Organization criteria for the Asian population (< 25 kg/m² vs. ≥ 25 kg/m²). We compared the current and prior BMI, and found that the prior BMI is more significantly associated with colorectal cancer in the present study. Therefore, the prior BMI was used as an index for obesity. Second, physical activity was defined as conducting exercise regularly. Third, an unhealthy diet was defined based on the level of DII. Diet was classified as a low or high inflammatory diet based on the median intake levels of DII scores in the control group. Fourth, cigarette smoking was classified as ever or never. Smoking was chosen based on previous evidence and public health recommendations [7,21]. Fifth, people who drank more than 30 g of alcohol/day were considered heavy drinkers based on the association between alcohol consumption and colorectal cancer risk in the current study.

Finally, we assigned a lifestyle risk score (0 for healthy and 1 for unhealthy) to each participant and summed the scores of the five lifestyle factors; consequently, the lifestyle index ranged from zero (healthiest) to five (least healthy) points [11].

6. Statistical analysis

The differences in the demographic and lifestyle factors between the cases and controls were analyzed using the chi-squaqre test for categorical variables and Student’s t test for continuous variables.

The association between the risk factors (genetic and lifestyle risk factors) and colorectal cancer risk was analyzed using unconditional logistic regression models. The genetic risk score was calculated using 13 SNPs and divided into tertiles based on scores among controls: low (20%-30%), intermediate (50%-60%), and high (20%-30%). Because some of participants had the same risk scores, we could not divide subjects into the same proportion. The combined lifestyle factors were also divided into tertiles: low (defined as no or only one lifestyle risk factor), intermediate (defined as 2 or 3 lifestyle risk factors), and high (defined as four or five lifestyle risk factors). The lowest genetic or lifestyle risk factors were considered references. The multivariable model was adjusted for age, sex, family history of colorectal cancer, and education and additionally adjusted for the five modifiable risk factors (i.e., prior BMI, physical activity, DII, smoking, and alcohol consumption) as needed. Furthermore, we conducted a stratified analysis of the association between the lifestyle risk factors and colorectal cancer risk according to the genetic risk category. We used the results based on the unweighted and weighted risk score in further analyses. A multinomial logistic regression model was used in the analyses stratified by anatomical location (i.e., colon and rectal cancer). Interactions between genetic risk scores and lifestyle risk scores were assessed using the likelihood ratio test by comparing the model with the interaction term, with the model containing only main effects.

All statistical analyses were performed using SAS 9.2 (SAS Institute Inc., Cary, NC) and STATA ver. 14 software (Stata Corp., College Station, TX). A two-sided p-value of less than 0.05 indicated statistical significance.

7. Ethical statement

All participants provided written informed consent, and the study protocol was approved by the Institutional Review Board of the National Cancer Center (IRB No. NCCNCS-10-350 and NCC2015-0202).

Results

Table 1 shows the general characteristics of the study populations. The colorectal cancer patients had a higher family history (p=0.029), had a low education level (p < 0.001), were unlikely to perform regular exercise (p < 0.001), and had a higher energy intake (p < 0.001) and higher DII (p < 0.001). However, no differences were observed in age, sex, smoking, and alcohol intake. The cases did not differ from the controls in their current BMI but had a higher prior BMI (p < 0.001).

The association between colorectal cancer and selected SNPs among the 30 investigated polymorphisms was examined; only 13 SNPs were significantly associated with colorectal cancer (S3 Table). Several SNPs showed slightly different associations between the colon cancer and rectal cancer patients.

Table 2 presents the association between the genetic risk score and the risk of colorectal cancer. In this study, the genetic risk scores were approximately normally distributed. The unweighted and weighted genetic risk scores ranged between 5 and 23 (mean±SD, 14.40±3.17) and between 0.93 and 4.63 (mean±SD, 2.92±0.61), respectively. Compared to the lowest tertile, those in the highest tertile had a higher risk of colorectal cancer according to both the unweighted (odds ratio [OR], 2.87; 95% confidence interval [CI], 2.05 to 4.01 for the highest vs. lowest tertile) and weighted (OR, 2.57; 95% CI, 1.89 to 3.49 for the highest vs. lowest tertile) genetic risk scores. After stratifying by anatomical site, these associations were slightly stronger among patients with rectal cancer than those with colon cancer. Additionally, after stratifying by age, slightly stronger association was observed among younger people (< 50 years) than older people (≥ 50 years) (S4 Table). The performance of the genetic risk score using the weighted genetic risk score was similar to that using a simple count of risk alleles.

Table 3 presents the association between the modifiable risk factors and the colorectal cancer risk. Among the investigated lifestyle factors, the prior BMI, physical inactivity, heavy alcohol consumption, and high DII score were associated with an increased risk of colorectal cancer. All factors combined resulted in a lifestyle risk score that was highly associated with an increased risk of colorectal cancer (OR, 5.82; 95% CI, 4.02 to 8.44 for the highest vs. lowest tertile). After stratifying the data by anatomical site, the association observed among the colon cancer patients (OR, 6.23; 95% CI, 3.89 to 9.96 for the highest vs. lowest risk score) was slightly stronger than that among the rectal cancer patients (OR, 5.72; 95% CI, 3.60 to 9.08 for the highest vs. lowest risk score).

The combined effect of the genetic risk score and lifestyle risk score on the risk of colorectal cancer is shown in Table 4. Both the genetic risk scores and the lifestyle risk scores were divided into tertiles. As the genetic risk score increased into the highest tertile, the colorectal cancer risk increased. Additionally as the lifestyle risk score increased into the highest tertile, the colorectal cancer risk increased even more. In the analysis using unweighted genetic risk score (GRS), the participants in the highest tertile for both the genetic risk score and lifestyle risk score had an approximately 12 times higher risk of colorectal cancer than those in the lowest tertile for both the genetic risk score and lifestyle risk score (OR, 12.57; 95% CI, 5.77 to 27.39). This association seems to be stronger among the rectal cancer patients (OR, 17.71; 95% CI, 5.80 to 54.04) than that among the colon cancer patients (OR, 10.34; 95% CI, 4.16 to 25.71). The analysis using weighted GRS also shows similar associations. The association was similar in each genetic category.

Discussion

In the present study, the inherited genetic variation and lifestyle factors contributed independently to the susceptibility to colorectal cancer. According to the stratified analysis by genetic risk, the modifiable lifestyle risk factors were associated with similar risk increases in colorectal cancer risk across each stratum of genetic risk. The combined effects of genetics and lifestyle on the risk of colorectal cancer were stronger in the rectal cancer patients than those in the colon cancer patients.

The contribution of an inherited genetic predisposition to the causation of sporadic colorectal cancer remains unclear. In twin studies using combined data from three Nordic countries, colorectal cancer was shown to be relatively more heritable than other cancer types [2]. Recently, genome-wide association studies have identified several common genetic markers that are significantly associated with colorectal cancer [3-6]. Although the predicted risk conferred by each individual polymorphism tends to be modest, together, these polymorphisms have cumulative effects on colorectal cancer risk [2,22]. Therefore, several studies used a combined genetic risk score to elucidate the effect of heritability on colorectal cancer [3,10]. In a case-cohort study, Jung et al. [3] reported that participants in the highest quartiles of the genetic risk score had an elevated risk of colorectal cancer (hazard ratio, 2.65; 95% CI, 1.43 to 4.91) compared with those in the lowest quartile using seven SNPs. In the present study, we used 13 SNPs to calculate the genetic risk score and found a cumulatively increased risk of colorectal cancer among those carrying multiple risk alleles. In addition, the estimated hereditary components in the younger participants were slightly higher than those in the older participants; this finding is consistent with observations in which the hereditary effects were the stron-gest in patients with early-onset cancers [2,18]. According to the present study, calculated genetic risk score might be useful in identifying high-risk subjects carrying multiple risk alleles [22].

Lifestyle plays a principal role in causing colorectal cancer. In the present study, heavy alcohol consumption, obesity, physical inactivity, and an unhealthy diet were independent risk factors for colorectal cancer, and the combined risk score of the five risk factors was strongly associated with the risk of colorectal cancer. Several previous studies have examined the association between combined lifestyle factors and the incidence of colorectal cancer [11-14]. In a Danish cohort study, individuals with an increasing number of healthy lifestyle factors (i.e., physical activity, smoking status, alcohol consumption, certain dietary components, and waist circumference) experienced a stepwise decrease in the risk of colon cancer during the follow-up period [11]. In the Healthy Professional Follow-up study, a risk score composed of BMI, physical inactivity, alcohol consumption, smoking habits, red meat consumption, and folic acid supplement use showed that a poorer lifestyle was associated with an increased risk of developing colon cancer [12]. In the present study, we selected lifestyle factors and cut-offs based on the literature and our data, and suggested that the risk of colorectal cancer can be reduced by changing lifestyles [23]. Even though the influence of many risk factors on colorectal cancer may be very complex depending on age and other exposures, this simple score may guide to the general population to modify their lifestyle.

The exact mechanism by which the combined lifestyle and genetic factors affect the risk for colorectal cancer is unknown. The plausible biological effects of each factor are pleiotropic in nature and likely involve overlapping influence on pathways that are relevant to colorectal cancer development. Obesity, physical activity, and an unhealthy diet may contribute to metabolic syndrome, insulin resistance, modification of hormonal levels, immune function, inflammation, gastrointestinal transit time, and bile acid metabolism [16,24]. Cigarettes contain more than 7,000 dangerous chemicals comprising different carcinogens and cigarette smoking also increases inflammation [25]. However, the effects of these lifestyle factors may differ based on individuals’ genetic susceptibility because certain gene could be expressed only when activated by environmental factors [23]. Therefore, gene-environment interactions have a significant influence on the susceptibility to colorectal cancer. Furthermore, colorectal cancer is a heterogeneous disease. The colon and rectum serve different physiological functions and have different enzyme activities, fecal composition, bile acid metabolism, and intestinal transit time [26,27]. Therefore, colorectal cancer has different genetic and environmental risk factors depending on the anatomical location and different molecular pathways of carcinogenesis [28,29]. In the present study, the higher genetic and lifestyle risk groups seems to be at a higher risk of developing rectal cancer than developing colon cancer.

Risk stratification of target populations using simple questionnaires or genetic testing may be helpful to identify individuals who should undergo colorectal cancer screening [30]. In addition, public health interventions must be conducted to modify lifestyles, particularly for those with a high genetic risk. The findings of the present study may help to provide strategy for preventing colorectal cancer. However, the findings of the current study should be interpreted with caution because of the following limitations. First, this is a case-control study and thus may contain potential selection and information bias. Controls who seek a screening center may be more health-conscious and have healthier lifestyle than the general population. Second, a certain degree of measurement error and misclassification of exposure to risk factors is inevitable. Third, the results of the stratified analyses may be more attenuated due to relatively small sample size [18].

In conclusion, adherence to a healthy lifestyle is associated with a substantially reduced risk of colorectal cancer regardless of individuals’ genetic risk, suggesting that genetic risk might be attenuated by a favorable lifestyle. Our study highlights the useful public health message that even modest differences in lifestyle might have a substantial impact on colorectal cancer risk and emphasizes the importance of convincing people to follow lifestyle recommendations.

Electronic Supplementary Material

Supplementary materials are available at Cancer Research and Treatment website (http://www.e-crt.org).

crt-2018-447-suppl1.pdf

crt-2018-447-suppl2.pdf

crt-2018-447-suppl3.pdf

crt-2018-447-suppl4.pdf

NOTES

Conflict of interest relevant to this article was not reported.

Acknowledgements

This work was supported by grants from the National Cancer Center in Korea (1710882, 1810090), the National Research Foundation of Korea (2015R1C1A2A01053728).

Table 1.

General characteristics of the study populations

	Control (n=1,295)	Case (n=632)	p-value
Age (yr)	56.0±5.1	56.4±9.6	0.380
Sex
Female	408 (31.5)	203 (32.1)	0.786
Male	887 (68.5)	429 (67.9)
Family history (yes)^a)	71 (5.5)	51 (8.1)	0.029
Education (yr)
< 12	605 (47.1)	472 (74.7)	< 0.001
≥ 12	679 (52.9)	160 (25.3)
BMI (kg/m²)
< 25	862 (66.6)	431 (68.2)	0.474
≥ 25	433 (33.4)	201 (31.8)
Prior BMI (kg/m²)^b)
< 25	827 (63.9)	322 (51.0)	< 0.001
≥ 25	468 (36.1)	310 (49.1)
Physical activity (yes)	771 (59.8)	207 (32.8)	< 0.001
Smoking
Never	565 (43.6)	286 (45.3)	0.500
Ever	730 (56.4)	346 (54.8)
Alcohol consumption
Never	380 (29.3)	192 (30.4)	0.640
Ever	915 (70.7)	440 (69.6)
Total calorie intake (kcal)	1,696.3±561.6	2,023.0±529.2	< 0.001
DII	0.94±2.24	1.77±1.97	< 0.001

Values are presented as mean±standard deviation or number (%). BMI, body mass index; DII, dietary inflammatory index.

^a) First-degree relative,

^b) BMI from 2 years ago.

Table 2.

Association between genetic risk score and colorectal cancer risk, stratified by anatomical site^a)

Genetic risk sore	No. of controls (%)	Colorectal cancer		Colon cancer		Rectal cancer
Genetic risk sore	No. of controls (%)	No. (%)	OR (95% CI)^b)	No. (%)	OR (95% CI)^b)	No. (%)	OR (95% CI)^b)
Unweighted
≤ 11	273 (21.1)	80 (12.7)	1.0 (reference)	43 (13.5)	1.0 (reference)	37 (12.2)	1.0 (reference)
12-16	742 (57.3)	341 (54.0)	1.63 (1.20-2.21)	165 (51.9)	1.44 (0.98-2.10)	168 (55.3)	1.77 (1.18-2.64)
≥ 17	280 (21.6)	211 (33.4)	2.87 (2.05-4.01)	110 (34.6)	2.71 (1.80-4.09)	99 (32.6)	2.99 (1.93-4.63)
Weighted
T1	323 (24.9)	98 (15.5)	1.0 (reference)	52 (16.4)	1.0 (reference)	46 (15.1)	1.0 (reference)
T2	647 (50.0)	292 (46.2)	1.45 (1.09-1.94)	141 (44.3)	1.30 (0.91-1.87)	146 (48.1)	1.57 (1.08-2.28)
T3	352 (25.1)	242 (38.3)	2.57 (1.89-3.49)	125 (39.3)	2.46 (1.69-3.60)	112 (36.8)	2.59 (1.74-3.85)

CI, confidence interval; OR, odds ratio; T, tertile; SNP, single nucleotide polymorphism.

^a) Genetic risk score was calculated using 13 SNPs,

^b) Adjusted for age, sex, family history of colorectal cancer, education, obesity, physical activity, smoking, alcohol consumption, and dietary inflammatory index.

Table 3.

Association between modifiable risk factor and colorectal cancer risk, stratified by anatomical location

	No. of controls (%)	Colorectal cancer		Colon cancer		Rectal cancer
	No. of controls (%)	No. (%)	OR (95% CI)^a)	No. (%)	OR (95% CI)^a)	No. (%)	OR (95% CI)^a)
Prior BMI (kg/m²)^b)
< 25	827 (63.9)	322 (51.0)	1.0 (reference)	146 (45.9)	1.0 (reference)	166 (54.6)	1.0 (reference)
≥ 25	468 (36.1)	310 (49.1)	1.76 (1.43-2.18)	172 (54.1)	2.20 (1.69-2.87)	138 (45.4)	1.47 (1.12-1.93)
Physical activity
Yes	771 (59.8)	207 (32.8)	1.0 (reference)	117 (36.8)	1.0 (reference)	88 (29.0)	1.0 (reference)
No	518 (40.2)	425 (67.3)	2.71 (2.19-3.36)	201 (63.2)	2.26 (1.73-2.95)	216 (71.1)	3.25 (2.45-4.31)
Smoking
Never	565 (43.6)	286 (45.3)	1.0 (reference)	155 (48.7)	1.0 (reference)	125 (41.1)	1.0 (reference)
Ever	730 (56.4)	346 (54.8)	0.74 (0.55-0.98)	163 (51.3)	0.70 (0.49-0.99)	179 (58.9)	0.79 (0.55-1.14)
Alcohol (g/day)
≤ 30	1,154 (89.1)	501 (79.3)	1.0 (reference)	258 (81.1)	1.0 (reference)	234 (77.0)	1.0 (reference)
> 30	141 (10.9)	131 (20.7)	1.88 (1.40-2.53)	60 (18.9)	1.76 (1.22-2.55)	70 (23.0)	2.02 (1.41-2.89)
DII
Low	647 (50.0)	242 (38.3)	1.0 (reference)	125 (39.3)	1.0 (reference)	114 (37.5)	1.0 (reference)
High	648 (50.0)	390 (61.7)	1.38 (1.12-1.71)	193 (60.7)	1.39 (1.06-1.81)	190 (62.5)	1.37 (1.04-1.80)
Lifestyle risk score^c)
0 or 1	458 (35.5)	121 (19.2)	1.0 (reference)	60 (18.9)	1.0 (reference)	57 (18.9)	1.0 (reference)
2 or 3	727 (56.4)	376 (59.5)	2.24 (1.72-2.91)	195 (61.3)	2.51 (1.79-2.53)	176 (57.9)	2.08 (1.47-2.94)
4 or 5	104 (8.1)	135 (21.4)	5.82 (4.02-8.44)	63 (19.8)	6.23 (3.89-9.96)	71 (23.4)	5.72 (3.60-9.08)

OR, odds ratio; CI, confidence interval; BMI, body mass index; DII, dietary inflammatory index.

^a) Adjusted for age, sex, family history of colorectal cancer, and education. Additionally adjusted for prior BMI, physical activity, smoking, alcohol, and DII, if applicable,

^b) BMI from 2 years ago,

^c) Scored by summing the prior BMI (2 years ago), physical activity, smoking, alcohol consumption, and DII.

Table 4.

Association between colorectal cancer risk and combined risk score of genetic and lifestyle risk^a)

Lifestyle risk score	Genetic risk score^b)
Lifestyle risk score	Low	Intermediate	High
Unweighted genetic risk score
Colorectal cancer
Low	1.0 (reference)	1.32 (0.72-2.42)	2.81 (1.45-5.45)
Intermediate	1.78 (0.93-3.42)	3.30 (1.86-5.86)	5.42 (2.98-9.88)
High	6.29 (2.78-14.21)	8.67 (4.45-16.90)	12.57 (5.77-27.39)
Colon cancer
Low	1.0 (reference)	1.00 (0.48-2.07)	1.50 (0.65-3.46)
Intermediate	1.33 (0.60-2.95)	2.49 (1.26-4.93)	4.79 (2.37-9.69)
High	5.30 (2.01-13.98)	6.11 (2.74-13.64)	10.34 (4.16-25.71)
Rectal cancer
Low	1.0 (reference)	1.83 (0.68-4.91)	5.49 (1.99-15.12)
Intermediate	2.76 (0.99-7.68)	4.86 (1.90-12.43)	6.90 (2.63-18.11)
High	8.63 (2.66-27.99)	13.71 (4.97-37.83)	17.71 (5.80-54.04)
Weighted genetic risk score
Colorectal cancer
Low	1.0 (reference)	1.17 (0.66-2.07)	2.75 (1.51-5.03)
Intermediate	1.86 (1.03-3.33)	3.12 (1.84-5.29)	4.95 (2.88-8.52)
High	6.26 (2.94-13.33)	8.15 (4.29-15.48)	11.40 (5.63-23.09)
Colon cancer
Low	1.0 (reference)	0.93 (0.46-1.89)	1.62 (0.75-3.49)
Intermediate	1.44 (0.69-2.98)	2.47 (1.30-4.69)	4.57 (2.38-8.77)
High	5.70 (2.31-14.07)	5.99 (2.73-13.15)	9.49 (4.10-21.97)
Rectal cancer
Low	1.0 (reference)	1.47 (0.61-3.57)	4.53 (1.89-10.96)
Intermediate	2.61 (1.08-6.29)	4.15 (1.84-9.37)	5.63 (2.45-12.94)
High	7.49 (2.61-21.47)	11.89 (4.79-59.54)	14.46 (2.46-38.30)

^a) Adjusted for age, sex, family history of colorectal cancer, and education,

^b) Both weighted and unweighted genetic risk score were used.

REFERENCES

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. Article PubMed
2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78–85. Article PubMed
3. Jung KJ, Won D, Jeon C, Kim S, Kim TI, Jee SH, et al. A colorectal cancer prediction model using traditional and genetic risk scores in Koreans. BMC Genet. 2015;16:49.Article PubMed PMC PDF
4. Zhang B, Jia WH, Matsuda K, Kweon SS, Matsuo K, Xiang YB, et al. Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk. Nat Genet. 2014;46:533–42. Article PubMed PMC PDF
5. Jia WH, Zhang B, Matsuo K, Shin A, Xiang YB, Jee SH, et al. Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. Nat Genet. 2013;45:191–6. Article PubMed PDF
6. Houlston RS, Cheadle J, Dobbins SE, Tenesa A, Jones AM, Howarth K, et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet. 2010;42:973–7. Article PubMed PMC PDF
7. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer. 2009;125:171–80. Article PubMed
8. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59:366–78. Article PubMed
9. Aran V, Victorino AP, Thuler LC, Ferreira CG. Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality. Clin Colorectal Cancer. 2016;15:195–203. Article PubMed
10. Iwasaki M, Tanaka-Mizuno S, Kuchiba A, Yamaji T, Sawada N, Goto A, et al. Inclusion of a genetic risk score into a validated risk prediction model for colorectal cancer in Japanese men improves performance. Cancer Prev Res (Phila). 2017;10:535–41. Article PubMed PMC
11. Kirkegaard H, Johnsen NF, Christensen J, Frederiksen K, Overvad K, Tjonneland A. Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study. BMJ. 2010;341:c5504.Article PubMed PMC
12. Platz EA, Willett WC, Colditz GA, Rimm EB, Spiegelman D, Giovannucci E. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control. 2000;11:579–88. Article PubMed
13. Wei EK, Colditz GA, Giovannucci EL, Fuchs CS, Rosner BA. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study. Am J Epidemiol. 2009;170:863–72. Article PubMed PMC PDF
14. Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120:257–63. Article PubMed
15. Ahn Y, Kwon E, Shim JE, Park MK, Joo Y, Kimm K, et al. Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study. Eur J Clin Nutr. 2007;61:1435–41. Article PubMed PDF
16. Cho YA, Lee J, Oh JH, Shin A, Kim J. Dietary inflammatory index and risk of colorectal cancer: a case-control study in Korea. Nutrients. 2016;8:E469.Article
17. Shivappa N, Steck SE, Hurley TG, Hussey JR, Hebert JR. Designing and developing a literature-derived, populationbased dietary inflammatory index. Public Health Nutr. 2014;17:1689–96. Article PubMed
18. Song N, Shin A, Park JW, Kim J, Oh JH. Common risk variants for colorectal cancer: an evaluation of associations with age at cancer onset. Sci Rep. 2017;7:40644.Article PubMed PMC PDF
19. Brautbar A, Pompeii LA, Dehghan A, Ngwa JS, Nambi V, Virani SS, et al. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis. 2012;223:421–6. Article PubMed PMC
20. Stevens J, Juhaeri , Cai J. Changes in body mass index prior to baseline among participants who are ill or who die during the early years of follow-up. Am J Epidemiol. 2001;153:946–53. Article PubMed PDF
21. Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer. 2009;124:2406–15. Article PubMed
22. Dunlop MG, Tenesa A, Farrington SM, Ballereau S, Brewster DH, Koessler T, et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut. 2013;62:871–81. Article PubMed
23. Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008;25:2097–116. Article PubMed PMC PDF
24. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013;62:933–47. Article PubMed
25. Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, et al. Cigarette smoking and variations in systemic immune and inflammation markers. J Natl Cancer Inst. 2014;106:dju294.Article PubMed PMC PDF
26. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990;113:779–88. Article PubMed
27. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer. 2002;101:403–8. Article PubMed
28. Shin A, Joo J, Bak J, Yang HR, Kim J, Park S, et al. Site-specific risk factors for colorectal cancer in a Korean population. PLoS One. 2011;6:e23196Article PubMed PMC
29. Wei EK, Giovannucci E, Wu K, Rosner B, Fuchs CS, Willett WC, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer. 2004;108:433–42. Article PubMed PMC
30. Yeoh KG, Ho KY, Chiu HM, Zhu F, Ching JY, Wu DC, et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60:1236–41. Article PubMed

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Sleep Duration, Dietary Inflammatory Potential, and Obesity in Relation to Colorectal Cancer Incidence in the Multiethnic Cohort
Penias Tembo, Longgang Zhao, Loïc Le Marchand, Lynne R. Wilkens, Song-Yi Park, Christopher A. Haiman, Michael D. Wirth, James R. Hébert
Nutrients.2025; 17(3): 370. CrossRef
Design and Analysis of Surface Plasmon Resonance-Based Refractive Index Biosensor for Detection of Colorectal Cancer with Machine Learning Approach
Yahya Ali Abdelrahman Ali, Trupti Kamani, Shobhit K. Patel, Taoufik Saidani, Abdulkarem H. M. Almawgani, Basim Ahmad Alabsi
Plasmonics.2025;[Epub] CrossRef
CD38 gene polymorphism rs1130169 contribution to the increased gene expression and risk of colorectal cancer (pilot study)
Dmitry V. Novikov, Alexei D. Perenkov, Svetlana V. Shumilova, Nailya I. Kubysheva, Viktor V. Novikov
Molecular Biology Reports.2024;[Epub] CrossRef
Molecular subtype identification and prognosis stratification by a immunogenic cell death-related gene expression signature in colorectal cancer
Junping Lei, Jia Fu, Tianyang Wang, Yu Guo, Mingmin Gong, Tian Xia, Song Shang, Yan Xu, Ling Cheng, Binghu Lin
Expert Review of Anticancer Therapy.2024; 24(7): 635. CrossRef
Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk
Yu Tian, Yi Lin, Conghui Qu, Volker Arndt, James W. Baurley, Sonja I. Berndt, Stephanie A. Bien, D. Timothy Bishop, Hermann Brenner, Daniel D. Buchanan, Arif Budiarto, Peter T. Campbell, Robert Carreras-Torres, Graham Casey, Andrew T. Chan, Rui Chen, Xuec
British Journal of Cancer.2024; 130(10): 1687. CrossRef
A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population
Yuanlin Zou, Jicun Zhu, Caijuan Song, Tiandong Li, Keyan Wang, Jianxiang Shi, Hua Ye, Peng Wang
Cancer Medicine.2024;[Epub] CrossRef
Functionalized liposomes as a potential drug delivery systems for colon cancer treatment: A systematic review
Eskandar Moghimipour, Somayeh Handali
International Journal of Biological Macromolecules.2024; 269: 132023. CrossRef
UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer
Xuancheng Wang, Xuan Guan, Ying Tong, Yunxiao Liang, Zongsheng Huang, Mingsen Wen, Jichu Luo, Hongwei Chen, Shanyi Yang, Zhiyong She, Zhijuan Wei, Yun Zhou, Yali Qi, Pingchuan Zhu, Yanying Nong, Qisong Zhang
BMC Cancer.2024;[Epub] CrossRef
High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway
Feng Li, Xing Wan, Zhigui Li, Liming Zhou
Cancer Medicine.2024;[Epub] CrossRef
Relationship Between Aspirin Use and Site-Specific Colorectal Cancer Risk Among Individuals With Metabolic Comorbidity
Seokyung An, Madhawa Gunathilake, Jeonghee Lee, Minji Kim, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
Journal of Korean Medical Science.2024;[Epub] CrossRef
Microbiota in gastrointestinal malignancies
Ludovica Bricca, Serena Porcari, Edoardo Savarino, Massimo Rugge
Best Practice & Research Clinical Gastroenterology.2024; 72: 101953. CrossRef
Iron-(Fe3+)-Dependent Reactivation of Telomerase Drives Colorectal Cancers
Raghuvaran Shanmugam, Prativa Majee, Wei Shi, Mert B. Ozturk, Thamil S. Vaiyapuri, Khaireen Idzham, Anandhkumar Raju, Seung H. Shin, Kerem Fidan, Joo-Leng Low, Joelle Y.H. Chua, Yap C. Kong, Ong Y. Qi, Emile Tan, Aik Y. Chok, Isaac Seow-En, Ian Wee, Domin
Cancer Discovery.2024; 14(10): 1940. CrossRef
An atlas on risk factors for gastrointestinal cancers: A systematic review of Mendelian randomization studies
Yi-Xuan Huang, Jun-Hua Wu, Yu-Qiang Zhao, Wan-Nian Sui, Tian Tian, Wen-Xiu Han, Jing Ni
Preventive Medicine.2024; 189: 108147. CrossRef
Potential regulatory mechanism and clinical significance of synaptotagmin binding cytoplasmic RNA interacting protein in colorectal cancer
Hui Li, He-Qing Huang, Zhi-Guang Huang, Rong-Quan He, Ye-Ying Fang, Rui Song, Jia-Yuan Luo, Da-Tong Zeng, Kai Qin, Dan-Ming Wei, Gang Chen
World Journal of Clinical Oncology.2024; 15(11): 1412. CrossRef
KRAS Gene Mutation Associated with Grade of Tumor Budding and Peripheral Immunoinflammatory Indices in Patients with Colorectal Cancer
Liu Liang, Xuemin Guo, Wei Ye, Yuxiang Liu
International Journal of General Medicine.2024; Volume 17: 4769. CrossRef
Specifics of cancer detection at the outpatient stage. A case report
O.S. Skuratova, S.N. Lagutina, P.Yu. Poyminova, A.E. Guzenko, G.A. Tyukov, A.A. Pashkova, N.S. Korchagina, E.Yu. Esina, I.S. Dobrynina
Russian Journal of Preventive Medicine.2024; 27(10): 97. CrossRef
Association of Methylenetetrahydrofolate Reductase Gene rs1801133 Polymorphism and Controlling Nutritional Status (CONUT) Score with Colorectal Cancer Susceptibility
Zhuoxin Zhang, Zuguang Wu, Yuwen Zeng, Yunlin Li, Yingchuan Feng, Zhen Gao, Yijin Chen
International Journal of General Medicine.2024; Volume 17: 6281. CrossRef
Physical activity, polygenic risk score, and colorectal cancer risk
Xuechen Chen, Feng Guo, Jenny Chang‐Claude, Michael Hoffmeister, Hermann Brenner
Cancer Medicine.2023; 12(4): 4655. CrossRef
Lifestyle, genetic risk and incidence of cancer: a prospective cohort study of 13 cancer types
Stephanie Byrne, Terry Boyle, Muktar Ahmed, Sang Hong Lee, Beben Benyamin, Elina Hyppönen
International Journal of Epidemiology.2023; 52(3): 817. CrossRef
Association of blood pressure with incident diabetic microvascular complications among diabetic patients: Longitudinal findings from the UK Biobank
Cong Li, Honghua Yu, Zhuoting Zhu, Xianwen Shang, Yu Huang, Charumathi Sabanayagam, Xiaohong Yang, Lei Liu
Journal of Global Health.2023;[Epub] CrossRef
Analysis of factors associated with postoperative acute kidney injury in patients with colorectal cancer and the development of a risk prediction model: a retrospective study
Liu Li, Xiaochen Wan, Yonglei Zhang, Minghai Zhao, Jinjun Ren, Yongchao Zhang
Updates in Surgery.2023; 75(5): 1171. CrossRef
Exosomal Circ_FMN2 Derived from the Serum of Colorectal Cancer Patients Promotes Cancer Progression by miR-338-3p/MSI1 Axis
Qiyao Yu, Yi Zhang, Yanming Tian, Ale Peng, Xiujing Cui, Boyue Ding, Lei Yang, Yabin Liu, Yingchao Ju, Chao Gao
Applied Biochemistry and Biotechnology.2023; 195(12): 7322. CrossRef
Green space exposure and colorectal cancer: A systematic review
Noor Azreen Masdor, Maryam Fatimah Abu Bakar, Rozita Hod, Azmawati Mohammed Nawi
Heliyon.2023; 9(5): e15572. CrossRef
The Anti-Adhesion Effect of Nisin as a Robust Lantibiotic on the Colorectal Cancer Cells
Hesam Soleimanifar, Hamideh Mahmoodzadeh Hosseini, Sadra Samavarchi Tehrani, Seyed Ali Mirhosseini
Advanced Biomedical Research.2023;[Epub] CrossRef
Colorectal cancer: epidemiology, carcinogenesis, molecular subtypes and cellular mechanisms of therapy resistance (analytical review)
P. E. Maksimova, E. P. Golubinskaya, B. D. Seferov, E. Yu. Zyablitskaya
Koloproktologia.2023; 22(2): 160. CrossRef
The crosstalk between ubiquitin-conjugating enzyme E2Q1 and p53 in colorectal cancer: An in vitro analysis
Maryam Rasouli, Sara Khakshournia, Omid Vakili, Sanaz Dastghaib, Atefeh Seghatoleslam, Sayed Mohammad Shafiee
Medical Oncology.2023;[Epub] CrossRef
Does postcholecystectomy increase the risk of colorectal cancer?
Zhenyu Dong, Ruixian Shi, Pengda Li, Xiaobiao Song, Fan Dong, Jianmin Zhu, Riga Wu, Zhi Liang, Mingyue Du, Jijun Wang, Zhigang Yang
Frontiers in Microbiology.2023;[Epub] CrossRef
Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer
Joanna Słoka, Marcel Madej, Barbara Strzalka-Mrozik
Molecules.2023; 28(13): 5081. CrossRef
Colorectal Cancer: From Risk Factors to Oncogenesis
Vlad Alexandru Ionescu, Gina Gheorghe, Nicolae Bacalbasa, Alexandru Laurentiu Chiotoroiu, Camelia Diaconu
Medicina.2023; 59(9): 1646. CrossRef
Modifiable Risk Factors in High-Risk Groups of Colorectal Cancer Screening: A Cross-Sectional Study with Propensity Score Method
Xuan Zhong, Nongping Feng, Binfa Ouyang, Dan Zhao, Lin Lei, Ji Peng, Xiaolin Peng
Risk Management and Healthcare Policy.2023; Volume 16: 2673. CrossRef
Bioactive Peptides: Potential Impact on the Treatment of Gastrointestinal Cancers
Ghazaleh Pourali, Danial Kazemi, Roozbeh Pourali, Nafise Rahmani, Erfan Razzaghi, Mina Maftooh, Hamid Fiuji, Elnaz Ghorbani, Majid Khazaei, Gordon A. Ferns, Seyed Mahdi Hassanian, Amir Avan
Current Pharmaceutical Design.2023; 29(31): 2450. CrossRef
A novel nutritional risk score and prognosis of oral cancer patients: A prospective study
Qing Chen, Yi Fan, Yanni Li, Jing Wang, Lin Chen, Jing Lin, Fa Chen, Jing Wang, Yu Qiu, Bin Shi, Lizhen Pan, Lisong Lin, Baochang He, Fengqiong Liu
Oral Diseases.2022; 28(1): 108. CrossRef
Antecedentes familiares de primer grado como factor de riesgo en el cáncer colorrectal
María Rubín-García, Vicente Martín, Facundo Vitelli-Storelli, Víctor Moreno, Nuria Aragonés, Eva Ardanaz, Jéssica Alonso-Molero, José J. Jiménez-Moleón, Pilar Amiano, Guillermo Fernández-Tardón, Ana Molina-Barceló, Juan Alguacil, María Dolores-Chirlaque,
Gaceta Sanitaria.2022; 36(4): 345. CrossRef
Diet and Genetic Risk Factors of Colorectal Cancer in Palestine: A Case-Control Study
Issa Ghrouz, Nuha El Sharif
Nutrition and Cancer.2022; 74(7): 2460. CrossRef
Polygenic risk prediction models for colorectal cancer: a systematic review
Michele Sassano, Marco Mariani, Gianluigi Quaranta, Roberta Pastorino, Stefania Boccia
BMC Cancer.2022;[Epub] CrossRef
Meta-Analysis of the Association between Dietary Inflammatory Index (DII) and Colorectal Cancer
Sharifah Saffinas Syed Soffian, Azmawati Mohammed Nawi, Rozita Hod, Mohd Hasni Ja’afar, Zaleha Md Isa, Huan-Keat Chan, Muhammad Radzi Abu Hassan
Nutrients.2022; 14(8): 1555. CrossRef
Lack of Association Between PDCD-1 Polymorphisms and Colorectal Cancer Risk: A Case-Control Study
Jing Lin, Hanshen Chen, Yufang Huang, Weifeng Tang, Sheng Zhang, Yu Chen
Immunological Investigations.2022; 51(6): 1867. CrossRef
Pro-Oxidant and Cytotoxic Effects of Tucum-Do-Cerrado (Bactris setosa Mart.) Extracts in Colorectal Adenocarcinoma Caco-2 Cells
Renata Cristina da Silva, Raphael Rosa Fagundes, Klaas Nico Faber, Élida Geralda Campos
Nutrition and Cancer.2022; 74(10): 3723. CrossRef
Incidence, Mortality Features and Lifetime Risk Estimation of Digestive Tract Cancers in an Urban District of Shanghai, China
Jing-Hao Bi, Hui-Yun Yuan, Yu Jiang, Yun Zhang, Wen-Wei Zheng, Lei Zhang, Zhuo-Ying Li, Hong-Lan Li, Yu-Ting Tan, Wen-Sui Zhao, Yong-Bing Xiang
Journal of Epidemiology and Global Health.2022; 12(3): 248. CrossRef
Combined Effect of Healthy Lifestyle Factors and Risks of Colorectal Adenoma, Colorectal Cancer, and Colorectal Cancer Mortality: Systematic Review and Meta-Analysis
Jiazhou Yu, Qi Feng, Jean H. Kim, Yimin Zhu
Frontiers in Oncology.2022;[Epub] CrossRef
In silico high throughput screening and in vitro validation of a novel Raf/Mek dual inhibitor against colorectal carcinoma
Hassan M. Otifi
Biologia.2022; 77(12): 3555. CrossRef
The importance of regulatory pathway mediated by Circ0001955 in colorectal cancer
Sepideh Kadkhoda, Soudeh Ghafouri-Fard, Farshid Noorbakhsh, Sima Ravaei, Farzaneh Darbeheshti, Mahsa M. Amoli, Reza Taslimi, Abbas Shakoori
Experimental and Molecular Pathology.2022; 128: 104819. CrossRef
Early detection of colorectal cancer based on circular DNA and common clinical detection indicators
Jian Li, Tao Jiang, Zeng-Ci Ren, Zhen-Lei Wang, Peng-Jun Zhang, Guo-An Xiang
World Journal of Gastrointestinal Surgery.2022; 14(8): 833. CrossRef
The Role of CEP55 Expression in Tumor Immune Response and Prognosis of Patients with Non-small Cell lung Cancer
Haiyin Fan, Jin Zhang, Bin Zou, Zhisheng He
Archives of Iranian Medicine.2022; 25(7): 432. CrossRef
Exposome approach for identifying modifiable factors for the prevention of colorectal cancer
Nanqian Chen, Hailun Liang, Tao Huang, Ninghao Huang
Scientific Reports.2022;[Epub] CrossRef
Metabolic pathways in sporadic colorectal carcinogenesis: A new proposal
Sandra Caramujo-Balseiro, Carlos Faro, Lina Carvalho
Medical Hypotheses.2021; 148: 110512. CrossRef
Lifestyle Risk Score: handling missingness of individual lifestyle components in meta-analysis of gene-by-lifestyle interactions
Hanfei Xu, Karen Schwander, Michael R. Brown, Wenyi Wang, R. J. Waken, Eric Boerwinkle, L. Adrienne Cupples, Lisa de las Fuentes, Diana van Heemst, Oyomoare Osazuwa-Peters, Paul S. de Vries, Ko Willems van Dijk, Yun Ju Sung, Xiaoyu Zhang, Alanna C. Morris
European Journal of Human Genetics.2021; 29(5): 839. CrossRef
Inhibition of indoleamine 2,3-dioxygenase 1 synergizes with oxaliplatin for efficient colorectal cancer therapy
Xiaofei Miao, Ye Zhang, Zengyao Li, Longchang Huang, Taojian Xin, Renhui Shen, Tong Wang
Molecular Therapy - Methods & Clinical Development.2021; 20: 442. CrossRef
Polygenic risk score, healthy lifestyles, and risk of incident depression
Zhi Cao, Hongxi Yang, Yixuan Ye, Yuan Zhang, Shu Li, Hongyu Zhao, Yaogang Wang
Translational Psychiatry.2021;[Epub] CrossRef
Analysis of multi-omics differences in left-side and right-side colon cancer
Yanyi Huang, Jinzhong Duanmu, Yushu Liu, Mengyun Yan, Taiyuan Li, Qunguang Jiang
PeerJ.2021; 9: e11433. CrossRef
Individual and Joint Associations of Genetic Risk and Healthy Lifestyle Score with Colorectal Neoplasms Among Participants of Screening Colonoscopy
Vanessa Erben, Prudence R. Carr, Feng Guo, Korbinian Weigl, Michael Hoffmeister, Hermann Brenner
Cancer Prevention Research.2021; 14(6): 649. CrossRef
Correlation between expression levels of lncRNA FER1L4 and RB1 in patients with colorectal cancer
Marjan Ostovarpour, Mohammad Khalaj-Kondori, Tayyebeh Ghasemi
Molecular Biology Reports.2021; 48(5): 4581. CrossRef
Solanaceous Vegetables and Colorectal Cancer Risk: A Hospital-Based Matched Case-Control Study in Northeast China
Yang Liu, Simin Li, Liqing Jiang, Yuchong Zhang, Zhi Li, Jing Shi
Frontiers in Nutrition.2021;[Epub] CrossRef
Lifestyle Score and Genetic Factors With Hypertension and Blood Pressure Among Adults in Rural China
Miaomiao Niu, Liying Zhang, Yikang Wang, Runqi Tu, Xiaotian Liu, Chongjian Wang, Ronghai Bie
Frontiers in Public Health.2021;[Epub] CrossRef
Importance of Circ0009910 in colorectal cancer pathogenesis as a possible regulator of miR-145 and PEAK1
Sepideh Kadkhoda, Reza Taslimi, Farshid Noorbakhsh, Farzaneh Darbeheshti, Javad Tavakkoly Bazzaz, Soudeh Ghafouri-Fard, Abbas Shakoori
World Journal of Surgical Oncology.2021;[Epub] CrossRef
Cancer death and potential years of life lost in Feicheng City, China
Jia Yang, Li Zhao, Nan Zhang, Zhenhua Du, Yanyan Li, Xia Li, Deli Zhao, Jialin Wang
Medicine.2021; 100(39): e27370. CrossRef
A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility
Justina Ucheojor Onwuka, Dapeng Li, Yupeng Liu, Hao Huang, Jing Xu, Ying Liu, Yuanyuan Zhang, Yashuang Zhao
BMC Cancer.2020;[Epub] CrossRef
A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis
Haitao Chen, Fan Zhang, Jin Zhang, Xinjie Zhang, Yong Guo, Qinghua Yao
Frontiers in Immunology.2020;[Epub] CrossRef
Gastric cancer risk: between genetics and lifestyle
Massimo Rugge
The Lancet Oncology.2020; 21(10): 1258. CrossRef
Barriers of colorectal cancer screening test among adults in the Saudi Population: A Cross-Sectional study
Shatha A. Alduraywish, Leen A. Altamimi, Ashwaq A. Almajed, Bushra A. Kokandi, Rawan S. Alqahtani, Shatha G. Alghaihb, Fahad M. Aldakheel
Preventive Medicine Reports.2020; 20: 101235. CrossRef
Protective Effect of Green Tea Consumption on Colorectal Cancer Varies by Lifestyle Factors
Hyejin Kim, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
Nutrients.2019; 11(11): 2612. CrossRef
The Effect of Aerobic Training with Purslane (Portulaca Oleracea) Seed on Toll Like Receptors in Colon Tumor Tissue of Adult Rats with Colon Cancer
Abdol Kheder Keshtvarz, Maghsoud Peeri, Mohammad Ali Azarbayjani, Seyed Ali Hosseini
Jorjani Biomedicine Journal.2019; 7(4): 49. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Genetic Risk Score, Combined Lifestyle Factors and Risk of Colorectal Cancer

Cancer Res Treat. 2019;51(3):1033-1040. Published online October 18, 2018

DOI: https://doi.org/10.4143/crt.2018.447

XML Download

Top of article

Abstract
Introduction
Materials and Methods
Results
Discussion
Electronic Supplementary Material
NOTES
REFERENCES

Genetic Risk Score, Combined Lifestyle Factors and Risk of Colorectal Cancer

	Control (n=1,295)	Case (n=632)	p-value
Age (yr)	56.0±5.1	56.4±9.6	0.380
Sex
Female	408 (31.5)	203 (32.1)	0.786
Male	887 (68.5)	429 (67.9)
Family history (yes)^a)	71 (5.5)	51 (8.1)	0.029
Education (yr)
< 12	605 (47.1)	472 (74.7)	< 0.001
≥ 12	679 (52.9)	160 (25.3)
BMI (kg/m²)
< 25	862 (66.6)	431 (68.2)	0.474
≥ 25	433 (33.4)	201 (31.8)
Prior BMI (kg/m²)^b)
< 25	827 (63.9)	322 (51.0)	< 0.001
≥ 25	468 (36.1)	310 (49.1)
Physical activity (yes)	771 (59.8)	207 (32.8)	< 0.001
Smoking
Never	565 (43.6)	286 (45.3)	0.500
Ever	730 (56.4)	346 (54.8)
Alcohol consumption
Never	380 (29.3)	192 (30.4)	0.640
Ever	915 (70.7)	440 (69.6)
Total calorie intake (kcal)	1,696.3±561.6	2,023.0±529.2	< 0.001
DII	0.94±2.24	1.77±1.97	< 0.001

Genetic risk sore	No. of controls (%)	Colorectal cancer		Colon cancer		Rectal cancer
Genetic risk sore	No. of controls (%)	No. (%)	OR (95% CI)^b)	No. (%)	OR (95% CI)^b)	No. (%)	OR (95% CI)^b)
Unweighted
≤ 11	273 (21.1)	80 (12.7)	1.0 (reference)	43 (13.5)	1.0 (reference)	37 (12.2)	1.0 (reference)
12-16	742 (57.3)	341 (54.0)	1.63 (1.20-2.21)	165 (51.9)	1.44 (0.98-2.10)	168 (55.3)	1.77 (1.18-2.64)
≥ 17	280 (21.6)	211 (33.4)	2.87 (2.05-4.01)	110 (34.6)	2.71 (1.80-4.09)	99 (32.6)	2.99 (1.93-4.63)
Weighted
T1	323 (24.9)	98 (15.5)	1.0 (reference)	52 (16.4)	1.0 (reference)	46 (15.1)	1.0 (reference)
T2	647 (50.0)	292 (46.2)	1.45 (1.09-1.94)	141 (44.3)	1.30 (0.91-1.87)	146 (48.1)	1.57 (1.08-2.28)
T3	352 (25.1)	242 (38.3)	2.57 (1.89-3.49)	125 (39.3)	2.46 (1.69-3.60)	112 (36.8)	2.59 (1.74-3.85)

	No. of controls (%)	Colorectal cancer		Colon cancer		Rectal cancer
	No. of controls (%)	No. (%)	OR (95% CI)^a)	No. (%)	OR (95% CI)^a)	No. (%)	OR (95% CI)^a)
Prior BMI (kg/m²)^b)
< 25	827 (63.9)	322 (51.0)	1.0 (reference)	146 (45.9)	1.0 (reference)	166 (54.6)	1.0 (reference)
≥ 25	468 (36.1)	310 (49.1)	1.76 (1.43-2.18)	172 (54.1)	2.20 (1.69-2.87)	138 (45.4)	1.47 (1.12-1.93)
Physical activity
Yes	771 (59.8)	207 (32.8)	1.0 (reference)	117 (36.8)	1.0 (reference)	88 (29.0)	1.0 (reference)
No	518 (40.2)	425 (67.3)	2.71 (2.19-3.36)	201 (63.2)	2.26 (1.73-2.95)	216 (71.1)	3.25 (2.45-4.31)
Smoking
Never	565 (43.6)	286 (45.3)	1.0 (reference)	155 (48.7)	1.0 (reference)	125 (41.1)	1.0 (reference)
Ever	730 (56.4)	346 (54.8)	0.74 (0.55-0.98)	163 (51.3)	0.70 (0.49-0.99)	179 (58.9)	0.79 (0.55-1.14)
Alcohol (g/day)
≤ 30	1,154 (89.1)	501 (79.3)	1.0 (reference)	258 (81.1)	1.0 (reference)	234 (77.0)	1.0 (reference)
> 30	141 (10.9)	131 (20.7)	1.88 (1.40-2.53)	60 (18.9)	1.76 (1.22-2.55)	70 (23.0)	2.02 (1.41-2.89)
DII
Low	647 (50.0)	242 (38.3)	1.0 (reference)	125 (39.3)	1.0 (reference)	114 (37.5)	1.0 (reference)
High	648 (50.0)	390 (61.7)	1.38 (1.12-1.71)	193 (60.7)	1.39 (1.06-1.81)	190 (62.5)	1.37 (1.04-1.80)
Lifestyle risk score^c)
0 or 1	458 (35.5)	121 (19.2)	1.0 (reference)	60 (18.9)	1.0 (reference)	57 (18.9)	1.0 (reference)
2 or 3	727 (56.4)	376 (59.5)	2.24 (1.72-2.91)	195 (61.3)	2.51 (1.79-2.53)	176 (57.9)	2.08 (1.47-2.94)
4 or 5	104 (8.1)	135 (21.4)	5.82 (4.02-8.44)	63 (19.8)	6.23 (3.89-9.96)	71 (23.4)	5.72 (3.60-9.08)

Lifestyle risk score	Genetic risk score^b)
Lifestyle risk score	Low	Intermediate	High
Unweighted genetic risk score
Colorectal cancer
Low	1.0 (reference)	1.32 (0.72-2.42)	2.81 (1.45-5.45)
Intermediate	1.78 (0.93-3.42)	3.30 (1.86-5.86)	5.42 (2.98-9.88)
High	6.29 (2.78-14.21)	8.67 (4.45-16.90)	12.57 (5.77-27.39)
Colon cancer
Low	1.0 (reference)	1.00 (0.48-2.07)	1.50 (0.65-3.46)
Intermediate	1.33 (0.60-2.95)	2.49 (1.26-4.93)	4.79 (2.37-9.69)
High	5.30 (2.01-13.98)	6.11 (2.74-13.64)	10.34 (4.16-25.71)
Rectal cancer
Low	1.0 (reference)	1.83 (0.68-4.91)	5.49 (1.99-15.12)
Intermediate	2.76 (0.99-7.68)	4.86 (1.90-12.43)	6.90 (2.63-18.11)
High	8.63 (2.66-27.99)	13.71 (4.97-37.83)	17.71 (5.80-54.04)
Weighted genetic risk score
Colorectal cancer
Low	1.0 (reference)	1.17 (0.66-2.07)	2.75 (1.51-5.03)
Intermediate	1.86 (1.03-3.33)	3.12 (1.84-5.29)	4.95 (2.88-8.52)
High	6.26 (2.94-13.33)	8.15 (4.29-15.48)	11.40 (5.63-23.09)
Colon cancer
Low	1.0 (reference)	0.93 (0.46-1.89)	1.62 (0.75-3.49)
Intermediate	1.44 (0.69-2.98)	2.47 (1.30-4.69)	4.57 (2.38-8.77)
High	5.70 (2.31-14.07)	5.99 (2.73-13.15)	9.49 (4.10-21.97)
Rectal cancer
Low	1.0 (reference)	1.47 (0.61-3.57)	4.53 (1.89-10.96)
Intermediate	2.61 (1.08-6.29)	4.15 (1.84-9.37)	5.63 (2.45-12.94)
High	7.49 (2.61-21.47)	11.89 (4.79-59.54)	14.46 (2.46-38.30)

Table 1. General characteristics of the study populations

Values are presented as mean±standard deviation or number (%). BMI, body mass index; DII, dietary inflammatory index.

First-degree relative,

BMI from 2 years ago.

Table 2. Association between genetic risk score and colorectal cancer risk, stratified by anatomical sitea)

CI, confidence interval; OR, odds ratio; T, tertile; SNP, single nucleotide polymorphism.

Genetic risk score was calculated using 13 SNPs,

Adjusted for age, sex, family history of colorectal cancer, education, obesity, physical activity, smoking, alcohol consumption, and dietary inflammatory index.

Table 3. Association between modifiable risk factor and colorectal cancer risk, stratified by anatomical location

OR, odds ratio; CI, confidence interval; BMI, body mass index; DII, dietary inflammatory index.

Adjusted for age, sex, family history of colorectal cancer, and education. Additionally adjusted for prior BMI, physical activity, smoking, alcohol, and DII, if applicable,

BMI from 2 years ago,

Scored by summing the prior BMI (2 years ago), physical activity, smoking, alcohol consumption, and DII.

Table 4. Association between colorectal cancer risk and combined risk score of genetic and lifestyle riska)